KRYS
Krystal Biotech, Inc.
Stock
$322.28−3.03 (−0.93%)Close Oct 2, 2026
- Capital expenditures, 2025
- $12M
- YoY, 2025
- +182.0%
- 5-year CAGR
- −4.2%
Capital expenditures
Capital expenditures by fiscal year
| Period | Capex | YoY |
|---|---|---|
| 2025 | $12M | +182.0% |
| 2024 | $4.2M | −64.1% |
| 2023 | $12M | −77.7% |
| 2022 | $53M | −22.5% |
| 2021 | $68M | +360.4% |
| 2020 | $15M | +132.0% |
| 2019 | $6.4M | +186.4% |
| 2018 | $2.2M | +963.8% |
| 2017 | $210K | +1,300.0% |
| 2016 | $15K | — |